Trazodone
Treatment for Frontotemporal Dementia
Typical Dosage: 50-300mg daily
Effectiveness
50%
Safety Score
55%
Clinical Trials
10
Participants
300
Comparative Safety Scale(Higher is safer)
Cyanideβ οΈ
Methπ
Cigarettesπ¬
Chemoβ’οΈ
AlcoholπΊ
Morphineπ
Antibioticsπ
Tylenolπ
Exerciseπ
Waterπ§
55
DangerousModerateSafe
Treatment Details
Dosage Range
50-300mg daily
Time to Effect
Hours for sedation, days to weeks for agitation
Treatment Duration
Lifetime
Evidence Quality
LOW-MODERATENumber Needed to Treat (NNT)
8(Treat 8 patients to see 1 additional successful outcome)
Confidence Score
60%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$30
Monitoring:$75
Side Effect Mgmt:$20
Total Annual:$125
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENTQALYs Gained
0.06
Outcome-Based Costs
Cost per Responder
$250
Trazodone Outcomes
for Frontotemporal Dementia
Efficacy Outcomes
Overall Effectiveness
+50%
Response Rate
+50%
Common Side Effects
Drowsiness
+35%
Dizziness
+18%
Orthostatic hypotension
+10%
Dry mouth
+15%
Priapism (rare)
+0.1%
Sources:
WARNING: LIMITED TRIALS AVAILABLE
You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!
Active Clinical Trials
No active trials currently recruiting for this treatment
No active trials found in ClinicalTrials.gov